KIF11 and neoplasm: This revealed (-)-Cochlactone A, Phelligridin C, Sterenin E, and Cyathusal A as Eg5 inhibitors with cytotoxic activity, nominating these compounds as scaffolds for developing additional Eg5-targeted drugs with enhanced anti-tumour efficacy [59,60].